ArticleBioinformatics (Oxford, England)2025
Leveraging large language models to predict antibiotic resistance in Mycobacterium tuberculosis.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advancements in artificial intelligence applications for the mitigation of antimicrobial resistance: challenges and opportunities.JAC-antimicrobial resistance · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationAntibiotic resistance in Mycobacterium tuberculosis (MTB) poses a significant challenge to global public health. Rapid and accurate prediction of antibiotic resistance can inform treatment strategies and mitigate the spread of resistant strains. In this study, we present a novel approach leveraging large language models (LLMs) to predict antibiotic resistance in MTB (LLMTB). Our model is trained and evaluated on genomic data from 12 185 CRyPTIC isolates and their associated resistance profiles, utilizing natural language processing techniques to capture patterns and mutations linked to resistance. The model's architecture integrates state-of-the-art transformer-based LLMs, enabling the analysis of complex genomic sequences and the extraction of critical features relevant to antibiotic resistance.
resultsWe evaluate our model's performance using a comprehensive dataset of MTB strains, demonstrating its ability to achieve high performance in predicting resistance to various antibiotics. Unlike traditional machine learning methods, fine-tuning or few-shot learning opens avenues for LLMs to adapt to new or emerging drugs, thereby reducing reliance on extensive data curation. Beyond predictive accuracy, LLMTB uncovers deeper biological insights, identifying critical genes, intergenic regions, and novel resistance mechanisms. This method marks a transformative shift in resistance prediction and offers significant potential for enhancing diagnostic capabilities and guiding personalized treatment plans, ultimately contributing to the global effort to combat tuberculosis and antibiotic resistance. AVAILABILITY AND IMPLEMENTATION: All source code is publicly available at https://github.com/ctestagrose/LLMTB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.